Press Releases

Overview

Press Releases

Presentations

Stock Information

Filings

2023 – Press Releases

NetraMark Closes Private Placement Financing

September 19, 2023 | NetraMark Holdings

Pharmaceutical Industry Veteran Joins NetraMark Advisory Board

July 19, 2023 | NetraMark Holdings

NetraMark Announces Engagement of ARU Global Inc.

June 21, 2023 | NetraMark Holdings

NetraMark Announces Uplist to the OTCQB Market

June 7, 2023 | NetraMark Holdings

NetraMark to Attend American Society of Clinical Oncology Conference in Chicago

June 1, 2023 | NetraMark Holdings

NetraMark engages ITG as Market Maker to enhance liquidity

May 9, 2023 | NetraMark Holdings

NetraMark Announces Closing of Private Placement

March 24, 2023 | NetraMark Holdings

NetraMark Releases Paper Demonstrating AI Capabilities to Derive Insights Using Clinical Scale Data

February 27, 2023 | NetraMark Holdings

NetraMark Private Placement – Press Release Clarification

September 15, 2023 | NetraMark Holdings

NetraMark Announces Shares for Debt Settlement

July 5, 2023 | NetraMark Holdings

NetraMark Closes Second and Final Tranche of Private Placement

June 14, 2023 | NetraMark Holdings

NetraMark Announces Increase to Private Placement Financing

June 6, 2023 | NetraMark Holdings

NetraMark to Participate in Renmark’s Virtual Non-Deal Roadshow

May 30, 2023 | NetraMark Holdings

NetraMark retains Renmark Financial Communications Inc.

May 5, 2023 | NetraMark Holdings

Healthcare Strategy Leader Joins NetraMark Advisory Board

March 21, 2023 | NetraMark Holdings

Introducing NetraMark – A Pharma AI Company

January 30, 2023 | NetraMark Holdings

NetraMark Announces Private Placement Financing

September 11, 2023 | NetraMark Holdings

NetraMark Enters into Advisor Agreement

June 22, 2023 | NetraMark Holdings

NetraMark Closes First Tranche of Private Placement

June 9, 2023 | NetraMark Holdings

NetraMark Announces Private Placement Financing

June 1, 2023 | NetraMark Holdings

NetraMark, the First Public AI Company to Launch Clinical Trial De-Risking Technology that Integrates ChatGPT

May 16, 2023 | NetraMark Holdings

NetraMark Successfully Delivers on Biopharma Client Contract

May 2, 2023 | NetraMark Holdings

NetraMark Uncovers Unique Alzheimer’s Disease Subtypes

March 15, 2023 | NetraMark Holdings